Splenectomy for refractory Evans' syndrome associated with antiphospholipid antibodies:: report of two cases

被引:18
作者
Font, J
Jiménez, S
Cervera, R
Garcia-Carrasco, M
Ramos-Casals, M
Campdelacreu, J
Ingelmo, M
机构
[1] Hosp Clin Barcelona, Unitat Malaties Autoimmunes Sistem, Hosp Clin Barcelona,Inst Invest Biomed August Pi, Sch Med,Syst Autoimmune Dis Unit,Dept Med, E-08036 Barcelona, Spain
[2] Benemerita Univ Puebla, Sch Med, Dept Immunol, Puebla, Mexico
关键词
D O I
10.1136/ard.59.11.920
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The main haematological manifestations seen in patients with antiphospholipid antibodies (aPL) are thrombocytopenia, usually mild, and haemolytic anaemia with a positive Coombs test. Owing to the shared characteristics with idiopathic thrombocytopenic purpura, similar rules are followed in the treatment of these cytopenias. Two patients with severe aPL associated cytopenias, who required splenectomy after being refractory to steroids, immunosuppressive agents, and other treatments (intravenous gammaglobulin, danazol), are described, and previously reported cases are reviewed.
引用
收藏
页码:920 / 923
页数:4
相关论文
共 20 条
  • [1] THE PRIMARY ANTIPHOSPHOLIPID SYNDROME - MAJOR CLINICAL AND SEROLOGICAL FEATURES
    ASHERSON, RA
    KHAMASHTA, MA
    ORDIROS, J
    DERKSEN, RHWM
    MACHIN, SJ
    BARQUINERO, J
    OUTT, HH
    HARRIS, EN
    VILARDELLTORRES, M
    HUGHES, GRV
    [J]. MEDICINE, 1989, 68 (06) : 366 - 374
  • [2] BALLERINI G, 1995, HAEMATOLOGICA, V80, P248
  • [3] ISOTYPE DISTRIBUTION OF ANTICARDIOLIPIN ANTIBODIES IN SYSTEMIC LUPUS-ERYTHEMATOSUS - PROSPECTIVE ANALYSIS OF A SERIES OF 100 PATIENTS
    CERVERA, R
    FONT, J
    LOPEZSOTO, A
    CASALS, F
    PALLARES, L
    BOVE, A
    INGELMO, M
    URBANOMARQUEZ, A
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 1990, 49 (02) : 109 - 113
  • [4] Morbidity and mortality in systemic lupus erythematosus during a 5-year period -: A multicenter prospective study of 1,000 patients
    Cervera, R
    Khamashta, MA
    Font, J
    Sebastiani, GD
    Gil, A
    Lavilla, P
    Aydintug, AO
    Jedryka-Góral, A
    de Ramón, E
    Fernández-Nebro, A
    Galeazzi, M
    Haga, HJ
    Mathieu, A
    Houssiau, F
    Ruiz-Irastorza, G
    Ingelmo, M
    Hughes, GRV
    [J]. MEDICINE, 1999, 78 (03) : 167 - 175
  • [5] CHESTERMAN CN, 1991, THROMB HAEMOSTASIS, V65, pA555
  • [6] Thrombocytopenia in the antiphospholipid syndrome
    Cuadrado, MJ
    Mujic, F
    Munoz, E
    Khamashta, MA
    Hughes, GRV
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 1997, 56 (03) : 194 - 196
  • [7] DAVIES KA, 1996, ANTIPHOSPHOLIPID SYN, P219
  • [8] DELPAPA N, 1992, CLIN EXP RHEUMATOL, V10, P395
  • [9] ACQUIRED HEMOLYTIC ANEMIA .1. THE RELATION OF ERYTHROCYTE ANTIBODY PRODUCTION TO ACTIVITY OF THE DISEASE .2. THE SIGNIFICANCE OF THROMBOCYTOPENIA AND LEUKOPENIA
    EVANS, RS
    DUANE, RT
    [J]. BLOOD, 1949, 4 (11) : 1196 - 1213
  • [10] ANTICARDIOLIPIN ANTIBODIES IN PATIENTS WITH AUTOIMMUNE-DISEASES - ISOTYPE DISTRIBUTION AND CLINICAL ASSOCIATIONS
    FONT, J
    CERVERA, R
    LOPEZSOTO, A
    PALLARES, L
    BOSCH, X
    AMPURDANES, S
    CASALS, FJ
    INGELMO, M
    [J]. CLINICAL RHEUMATOLOGY, 1989, 8 (04) : 475 - 483